Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McKay

Showing results (881-890 of 932) with videos related to

Pageof 94
Sort By:
Journal for Immunotherapy of Cancer|March 6, 2024
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromesAmin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, et al.
Clinical Genitourinary Cancer|July 6, 2023
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" ExperienceDimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, et al.
Cancer|December 1, 2024
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024Alan H Bryce, Neeraj Agarwal, Himisha Beltran, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2024
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2023
Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsK T Helzer, M N Sharifi, J M Sperger, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
The Lancet. Oncology|March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyNieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Pageof 94

Showing results (881-890 of 932) with videos related to

Sort By:
Pageof 94
Journal for Immunotherapy of Cancer|March 6, 2024
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromesAmin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, et al.
Clinical Genitourinary Cancer|July 6, 2023
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" ExperienceDimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, et al.
Cancer|December 1, 2024
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024Alan H Bryce, Neeraj Agarwal, Himisha Beltran, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2024
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024Edward M Schaeffer, Sandy Srinivas, Nabil Adra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2023
Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsK T Helzer, M N Sharifi, J M Sperger, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
The Lancet. Oncology|March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort studyNieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Pageof 94